Concepts (143)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lung Diseases, Interstitial | 5 | 2023 | 322 | 0.580 |
Why?
|
| Safety Management | 1 | 2008 | 54 | 0.280 |
Why?
|
| Monitoring, Physiologic | 1 | 2008 | 263 | 0.260 |
Why?
|
| Smartphone | 2 | 2017 | 53 | 0.240 |
Why?
|
| Trees | 1 | 2025 | 48 | 0.220 |
Why?
|
| Emphysema | 1 | 2023 | 24 | 0.190 |
Why?
|
| Pulmonary Emphysema | 1 | 2023 | 44 | 0.190 |
Why?
|
| Asthma | 3 | 2025 | 1078 | 0.180 |
Why?
|
| Muscle, Smooth | 4 | 2010 | 299 | 0.170 |
Why?
|
| Health Services Accessibility | 1 | 2025 | 532 | 0.160 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 1 | 2023 | 238 | 0.160 |
Why?
|
| Continuous Positive Airway Pressure | 1 | 2020 | 56 | 0.150 |
Why?
|
| Mediastinum | 1 | 2019 | 42 | 0.140 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2019 | 2666 | 0.140 |
Why?
|
| Patient Compliance | 1 | 2020 | 245 | 0.140 |
Why?
|
| Internship and Residency | 3 | 2017 | 1123 | 0.130 |
Why?
|
| Serum Response Factor | 2 | 2010 | 42 | 0.130 |
Why?
|
| Remote Sensing Technology | 1 | 2017 | 10 | 0.130 |
Why?
|
| Professional Misconduct | 1 | 2017 | 20 | 0.130 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2020 | 229 | 0.130 |
Why?
|
| Pulmonary Fibrosis | 1 | 2019 | 158 | 0.130 |
Why?
|
| Monitoring, Ambulatory | 1 | 2017 | 32 | 0.130 |
Why?
|
| Walk Test | 1 | 2017 | 38 | 0.130 |
Why?
|
| Respiratory Function Tests | 1 | 2017 | 163 | 0.120 |
Why?
|
| Internal Medicine | 2 | 2017 | 338 | 0.120 |
Why?
|
| Lung | 2 | 2023 | 1407 | 0.120 |
Why?
|
| Video Recording | 2 | 2017 | 218 | 0.120 |
Why?
|
| Advance Care Planning | 1 | 2016 | 45 | 0.120 |
Why?
|
| Mobile Applications | 1 | 2017 | 83 | 0.110 |
Why?
|
| Lymph Nodes | 1 | 2019 | 560 | 0.110 |
Why?
|
| Ethics, Medical | 1 | 2017 | 292 | 0.110 |
Why?
|
| Lung Diseases | 1 | 2017 | 284 | 0.110 |
Why?
|
| Predictive Value of Tests | 1 | 2019 | 1782 | 0.100 |
Why?
|
| Education | 1 | 2013 | 59 | 0.100 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2017 | 332 | 0.100 |
Why?
|
| Active Transport, Cell Nucleus | 2 | 2010 | 80 | 0.090 |
Why?
|
| Hospitalization | 1 | 2018 | 991 | 0.090 |
Why?
|
| Humans | 19 | 2025 | 98088 | 0.080 |
Why?
|
| Hospitalists | 1 | 2013 | 139 | 0.080 |
Why?
|
| Physicians | 1 | 2017 | 685 | 0.080 |
Why?
|
| Socioeconomic Factors | 2 | 2025 | 663 | 0.070 |
Why?
|
| Aged | 7 | 2022 | 21758 | 0.070 |
Why?
|
| Respiration, Artificial | 2 | 2022 | 462 | 0.070 |
Why?
|
| Male | 9 | 2025 | 47077 | 0.070 |
Why?
|
| Disease Progression | 2 | 2025 | 1610 | 0.070 |
Why?
|
| Clinical Competence | 1 | 2013 | 865 | 0.060 |
Why?
|
| Support Vector Machine | 2 | 2017 | 24 | 0.060 |
Why?
|
| Spirometry | 2 | 2017 | 78 | 0.060 |
Why?
|
| Female | 8 | 2025 | 51541 | 0.060 |
Why?
|
| Middle Aged | 6 | 2022 | 29428 | 0.060 |
Why?
|
| Cell Nucleus | 2 | 2010 | 615 | 0.060 |
Why?
|
| Aged, 80 and over | 3 | 2022 | 7389 | 0.050 |
Why?
|
| Residence Characteristics | 1 | 2025 | 224 | 0.050 |
Why?
|
| Tobacco Smoking | 1 | 2023 | 33 | 0.050 |
Why?
|
| Actins | 2 | 2003 | 480 | 0.050 |
Why?
|
| Bronchial Hyperreactivity | 1 | 2003 | 73 | 0.050 |
Why?
|
| Cohort Studies | 2 | 2020 | 3212 | 0.050 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2003 | 90 | 0.050 |
Why?
|
| Receptors, Muscarinic | 1 | 2002 | 42 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 2 | 2003 | 977 | 0.040 |
Why?
|
| Nitriles | 1 | 2022 | 171 | 0.040 |
Why?
|
| Muscle Contraction | 1 | 2003 | 269 | 0.040 |
Why?
|
| Prone Position | 1 | 2022 | 63 | 0.040 |
Why?
|
| Wakefulness | 1 | 2022 | 128 | 0.040 |
Why?
|
| Bronchi | 1 | 2003 | 229 | 0.040 |
Why?
|
| Retrospective Studies | 3 | 2023 | 10973 | 0.040 |
Why?
|
| Pyrazoles | 1 | 2022 | 160 | 0.040 |
Why?
|
| Chicago | 1 | 2025 | 1513 | 0.040 |
Why?
|
| Bayes Theorem | 1 | 2022 | 422 | 0.040 |
Why?
|
| Pyrimidines | 1 | 2022 | 413 | 0.040 |
Why?
|
| Gene Expression | 1 | 2003 | 1320 | 0.040 |
Why?
|
| Double-Blind Method | 1 | 2022 | 1782 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2025 | 4001 | 0.030 |
Why?
|
| Propensity Score | 1 | 2018 | 213 | 0.030 |
Why?
|
| Cause of Death | 1 | 2018 | 278 | 0.030 |
Why?
|
| Oxygen | 1 | 2022 | 802 | 0.030 |
Why?
|
| Hypoxia | 1 | 2022 | 699 | 0.030 |
Why?
|
| Genome, Human | 1 | 2002 | 832 | 0.030 |
Why?
|
| Adult | 3 | 2022 | 29539 | 0.030 |
Why?
|
| Accelerometry | 1 | 2017 | 49 | 0.030 |
Why?
|
| Pandemics | 1 | 2022 | 916 | 0.030 |
Why?
|
| Walking | 1 | 2017 | 114 | 0.030 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2022 | 1099 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2018 | 1009 | 0.030 |
Why?
|
| Inflammation | 1 | 2022 | 1120 | 0.030 |
Why?
|
| Outpatients | 1 | 2016 | 106 | 0.030 |
Why?
|
| United States | 2 | 2019 | 8197 | 0.030 |
Why?
|
| Prevalence | 1 | 2019 | 1384 | 0.030 |
Why?
|
| Survival Rate | 1 | 2019 | 2041 | 0.030 |
Why?
|
| Logistic Models | 1 | 2018 | 1275 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2020 | 2013 | 0.030 |
Why?
|
| Child | 1 | 2025 | 7681 | 0.020 |
Why?
|
| Educational Technology | 1 | 2013 | 17 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2017 | 1945 | 0.020 |
Why?
|
| Phenotype | 1 | 2019 | 2638 | 0.020 |
Why?
|
| Adolescent | 1 | 2025 | 10080 | 0.020 |
Why?
|
| Dogs | 2 | 2003 | 639 | 0.020 |
Why?
|
| Curriculum | 1 | 2016 | 633 | 0.020 |
Why?
|
| alpha Karyopherins | 1 | 2010 | 10 | 0.020 |
Why?
|
| Prognosis | 1 | 2019 | 4116 | 0.020 |
Why?
|
| Dimerization | 1 | 2010 | 149 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2010 | 139 | 0.020 |
Why?
|
| Academic Medical Centers | 1 | 2013 | 413 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2010 | 310 | 0.020 |
Why?
|
| Young Adult | 1 | 2022 | 7507 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2010 | 435 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2010 | 557 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2022 | 9711 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2017 | 3022 | 0.020 |
Why?
|
| Transcription, Genetic | 2 | 2003 | 1133 | 0.020 |
Why?
|
| Cells, Cultured | 2 | 2003 | 2855 | 0.020 |
Why?
|
| Protein Binding | 1 | 2010 | 1554 | 0.020 |
Why?
|
| Cell Line | 1 | 2010 | 2483 | 0.010 |
Why?
|
| Models, Biological | 1 | 2010 | 1807 | 0.010 |
Why?
|
| Bronchoconstrictor Agents | 1 | 2003 | 12 | 0.010 |
Why?
|
| Thiazolidines | 1 | 2003 | 15 | 0.010 |
Why?
|
| Muscle Cells | 1 | 2003 | 16 | 0.010 |
Why?
|
| Methacholine Chloride | 1 | 2003 | 61 | 0.010 |
Why?
|
| Amides | 1 | 2003 | 54 | 0.010 |
Why?
|
| Histamine | 1 | 2003 | 116 | 0.010 |
Why?
|
| Elasticity | 1 | 2003 | 98 | 0.010 |
Why?
|
| Myosin Heavy Chains | 1 | 2003 | 92 | 0.010 |
Why?
|
| Thiazoles | 1 | 2003 | 126 | 0.010 |
Why?
|
| Receptor, Muscarinic M3 | 1 | 2002 | 11 | 0.010 |
Why?
|
| Bacterial Toxins | 1 | 2003 | 113 | 0.010 |
Why?
|
| Bridged Bicyclo Compounds, Heterocyclic | 1 | 2003 | 112 | 0.010 |
Why?
|
| Trachea | 1 | 2003 | 249 | 0.010 |
Why?
|
| rho-Associated Kinases | 1 | 2003 | 162 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2002 | 380 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 2002 | 353 | 0.010 |
Why?
|
| Respiration | 1 | 2003 | 274 | 0.010 |
Why?
|
| Pyridines | 1 | 2003 | 318 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2003 | 403 | 0.010 |
Why?
|
| Exons | 1 | 2002 | 451 | 0.010 |
Why?
|
| Alternative Splicing | 1 | 2002 | 224 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2003 | 642 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2003 | 1950 | 0.010 |
Why?
|
| Mutation | 1 | 2010 | 4396 | 0.010 |
Why?
|
| Animals | 3 | 2003 | 28904 | 0.010 |
Why?
|
| Base Sequence | 1 | 2002 | 2222 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2002 | 911 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2002 | 2896 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2003 | 3620 | 0.010 |
Why?
|